The clinical course of bone metastases from breast cancer.

by Coleman, R. E., Rubens, R. D.
Published 1987

3(Amino-1,1-hydroxypropylidene) bisphosphonate (APD) for hypercalcaemia of breast cancer.

by Coleman, R. E., Rubens, R. D.
Published 1987

Clinical course and prognostic factors following bone recurrence from breast cancer.

by Coleman, R. E., Smith, P., Rubens, R. D.
Published 1998

Biochemical prediction of response of bone metastases to treatment.

by Coleman, R. E., Whitaker, K. B., Moss, D. W., Mashiter, G., Fogelman, I., Rubens, R. D.
Published 1988

Treatment of bone metastases from breast cancer with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).

by Coleman, R. E., Woll, P. J., Miles, M., Scrivener, W., Rubens, R. D.
Published 1988

Preliminary results of the use of urinary excretion of pyridinium crosslinks for monitoring metastatic bone disease.

by Coleman, R. E., Houston, S., James, I., Rodger, A., Rubens, R. D., Leonard, R. C., Ford, J.
Published 1992

Treatment of malignant hypercalcaemia with aminohexane bisphosphonate (neridronate).

by O'Rourke, N. P., McCloskey, E. V., Rosini, S., Coleman, R. E., Kanis, J. A.
Published 1994

Metabolic effects of pamidronate in patients with metastatic bone disease.

by Vinholes, J., Guo, C. Y., Purohit, O. P., Eastell, R., Coleman, R. E.
Published 1996

High-dose intravenous pamidronate for metastatic bone pain.

by Purohit, O. P., Anthony, C., Radstone, C. R., Owen, J., Coleman, R. E.
Published 1994

A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy.

by Purohit, O. P., Radstone, C. R., Anthony, C., Kanis, J. A., Coleman, R. E.
Published 1995

Hyperthyroidism and human chorionic gonadotrophin production in gestational trophoblastic disease

by Walkington, L, Webster, J, Hancock, B W, Everard, J, Coleman, R E
Published 2011

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) as a potent and persistent thyroxine agonist: a mechanistic model for toxicity based on molecular reactivity.

by McKinney, J D, Fawkes, J, Jordan, S, Chae, K, Oatley, S, Coleman, R E, Briner, W
Published 1985

A single administration of combination therapy inhibits breast tumour progression in bone and modifies both osteoblasts and osteoclasts

by Brown, H.K., Ottewell, P.D., Evans, C.A., Coleman, R.E., Holen, I.
Published 2012

Prednisolone improves the response to primary endocrine treatment for advanced breast cancer.

by Rubens, R. D., Tinson, C. L., Coleman, R. E., Knight, R. K., Tong, D., Winter, P. J., North, W. R.
Published 1988

Pulmonary function in patients with trophoblastic disease treated with low-dose methotrexate.

by Gillespie, A. M., Lorigan, P. C., Radstone, C. R., Waterhouse, J. C., Coleman, R. E., Hancock, B. W.
Published 1997

MAGE, BAGE and GAGE: tumour antigen expression in benign and malignant ovarian tissue.

by Gillespie, A. M., Rodgers, S., Wilson, A. P., Tidy, J., Rees, R. C., Coleman, R. E., Murray, A. K.
Published 1998

A phase II, multicentre, UK study of vinorelbine in advanced breast cancer.

by Twelves, C. J., Dobbs, N. A., Curnow, A., Coleman, R. E., Stewart, A. L., Tyrrell, C. J., Canney, P., Rubens, R. D.
Published 1994

Prevention of anastrozole induced bone loss with monthly oral ibandronate: Final 5 year results from the ARIBON trial

by Lester, J.E., Dodwell, D., Brown, J.E., Purohit, O.P., Gutcher, S.A., Ellis, S.P., Thorpe, R., Horsman, J.M., Coleman, R.E.
Published 2012

Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal events

by Smith, M. R., Coleman, R. E., Klotz, L., Pittman, K., Milecki, P., Ng, S., Chi, K. N., Balakumaran, A., Wei, R., Wang, H., Braun, A., Fizazi, K.
Published 2015

Patient-reported quality-of-life analysis of radium-223 dichloride from the phase III ALSYMPCA study

by Nilsson, S., Cislo, P., Sartor, O., Vogelzang, N. J., Coleman, R. E., O'Sullivan, J. M., Reuning-Scherer, J., Shan, M., Zhan, L., Parker, C.
Published 2016